ReviewFrontiers in immunology2018

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.

Derya Kabacaoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.